Author name: DrugPatentWatch

Introduction: Beyond Serendipity – The New Strategic Imperative For decades, the pharmaceutical industry has operated on a model of heroic, […]

The Russian pharmaceutical industry presents a formidable paradox. On one hand, it is a vast, multi-trillion-rouble arena demonstrating robust growth

Section 1: The CIS Pharmaceutical Arena: A Market of Contrasts and Opportunities The pharmaceutical landscape of the Commonwealth of Independent

Executive Summary The ascent of Brazil’s pharmaceutical giants represents one of the most compelling success stories in emerging market industrial

I. Executive Summary 1.1 Introduction: The New Mandate for Strategic IP Due Diligence The landscape of mergers and acquisitions (M&A)

Executive Summary The patent cliff is not a singular event but the catalyst for a predictable, multi-stage window of commercial

The global generic drug market is at a strategic inflection point, a moment of profound change and immense opportunity. Forecasts

Litigation Summary and Analysis for Bayer Intellectual Property GmbH v. Mankind Pharma Limited | 1:25-cv-01429 Introduction The lawsuit Bayer Intellectual

Introduction: Beyond Legal Defense—Non-Infringement as a Competitive Weapon A single chemical compound patent is not merely a legal document; it